Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni

NCT04679831 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Schistosoma Mansoni

Interventions

DIETARY_SUPPLEMENT: Ujiplus®
DRUG: Praziquantel 400mg

Sponsor

Kenya Medical Research Institute

Collaborators

[object Object]